Chairman's introduction--the importance of good quality surveillance data today.
The Alexander Project is a continuing, international, multicenter, longitudinal study of the antimicrobial susceptibility of pathogens commonly associated with community-acquired lower respiratory tract infections (LRTI). The study began in 1992 to provide high-quality surveillance data, comparable between regions and through time. As antimicrobial resistance becomes more prevalent, reliable surveillance data are required for clinical decision-making. Accurate current susceptibility data are required to predict clinical success through the determination of pharmacodynamic breakpoints. The Alexander Project provides the information required for clinicians to improve the likelihood of microbiological and clinical cure in the antibiotic treatment of LRTI.
Grüneberg
R N
RN
Department of Clinical Microbiology, University College London Hospital, UK.
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D017714:Community-Acquired Infections; D003625:Data Collection / Q000592:standards*; D003657:Decision Making; D004352:Drug Resistance, Microbial; D014943:Global Health; D006801:Humans; D008137:Longitudinal Studies; D011159:Population Surveillance; D011786:Quality Control; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000382:microbiology
D000900:Anti-Bacterial Agents